XML 32 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Loans
12 Months Ended
Dec. 31, 2022
Borrowings [abstract]  
Loans
10.    Loans
The following table presents the loan portfolio according to its classification and subsequent measurement:
December 31,
20222021
Loans, outstanding balance6,763,020 5,734,605 
Interest receivable69,965 23,308 
Loss allowance(55,200)(41,476)
Unearned interest and deferred fees(17,351)(8,728)
Loans at amortized cost6,760,434 5,707,709 
Loans at FVTPL (1)
— 5,313 
Loans, net6,760,434 5,713,022 

(1)The Bank sold financial instruments measured at FVTPL for $5.8 million, realizing a gain of $577 thousand recognized in the line item gain (loss) on financial instruments, net.
The fixed and floating interest rate distribution of the loan portfolio is as follows:
December 31,
20222021
Fixed interest rate3,827,083 3,327,310 
Floating interest rates2,935,937 2,412,608 
Total6,763,020 5,739,918 
As of December 31, 2022, and 2021, 79% and 71% of the loan portfolio at fixed interest rates has remaining maturities of less than 180 days. Interest rates on loans ranges from 1.27% to 15.32% (December 31, 2021 0.53% to 10.23%).
The following table details information relating to loans granted to class A and B shareholders:
December 31,
20222021
Loans to class A and B shareholders834,768 467,000 
% Loans to class A and B shareholders over total loan portfolio12 %%
% Class A and B stockholders with loans over number of class A and B stockholders11 %10 %
10.    Loans (continued)
Modified financial assets
As of December 31, 2022, the Bank does not have modified financial assets. The modified financial assets during 2021, where modification does not result in de-recognition, are presented below:
December 31,
2021
Gross carrying amount before modification65,000 
Allowance loss before modification (1)
(12,739)
Net amortized cost before modification52,261 
Gross carrying amount after modification65,000 
Allowance loss after modification (2)
(12,699)
Net amortized cost after modification52,301 
(1)12 - month ECL.
(2)Lifetime ECL.